|
Hodgkin Lymphoma Cancer Statistics
Get a free legal review of your case if your illness was caused by pollution.
Below are statistics relating to Hodgkin Lymphoma cancer from the National Cancer Institute (NCI). The data indicates trends, rates, and patterns of Hodgkin Lymphoma cancer in the United States, by sex, and race/ethnicity, survival and stage rates.
The National Cancer Institute (NCI) estimates that the incidence of cancer could be reduced by as much as 80-90 percent if environmental causes such as diet, tobacco, and alcohol, as well as radiation, infectious agents, and substances in the air, water, and soil were addressed.
If your cancer was caused by an industrial pollutant, or you were misdiagnosed by a doctor or oncologist, you may be able to seek compensation for your illness by filing a lawsuit against the negligent party. This, in turn, will help ensure the financial security of your family, as well as provide funds for medical treatment you may need.
For a free case evaluation, fill out this form. Your case will be evaluated shortly.
The American Cancer Society estimates that 7,350 men and women (3,980 men and 3,370 women) will be diagnosed with and 1,410 men and women will die of Hodgkin lymphoma in 2005.
The following information is based on NCI and other statistics from NCI’s analysis of SEER incidence data and NCHS mortality data.
Incidence & Mortality
From 1998-2002, the median age at diagnosis for Hodgkin lymphoma was 37 years of age. Approximately 12.5% were diagnosed under age 20; 32.9% between 20 and 34; 19.0% between 35 and 44; 12.0% between 45 and 54; 7.8% between 55 and 64; 8.4% between 65 and 74; 5.8% between 75 and 84; and 1.6% 85+ years of age.
The age-adjusted incidence rate was 2.7 per 100,000 men and women per year. These rates are based on cases diagnosed in 1998-2002 from 13 SEER geographic areas. Incidence rates by race and sex were:
| Race/Ethnicity | Men | Women |
|---|---|---|
| All Races | 3.0 per 100,000 men | 2.4 per 100,000 women |
| White | 3.3 per 100,000 men | 2.6 per 100,000 women |
| Black | 3.0 per 100,000 men | 2.0 per 100,000 women |
| Asian/Pacific Islander | 1.3 per 100,000 men | 1.0 per 100,000 women |
| American Indian/Alaska Native | ^ per 100,000 men | ^ per 100,000 women |
| Hispanic | 3.1 per 100,000 men | 1.9 per 100,000 women |
US Mortality
From 1998-2002, the median age at death for Hodgkin lymphoma was 60 years of age. Approximately 2.5% died under age 20; 16.2% between 20 and 34; 12.2% between 35 and 44; 12.6% between 45 and 54; 11.9% between 55 and 64; 18.1% between 65 and 74; 19.2% between 75 and 84; and 7.4% 85+ years of age.
The age-adjusted death rate was 0.5 per 100,000 men and women per year. These rates are based on patients who died in 1998-2002 in the US. Death rates by race and sex were:
| Race/Ethnicity | Men | Women |
|---|---|---|
| All Races | 0.6 per 100,000 men | 0.4 per 100,000 women |
| White | 0.6 per 100,000 men | 0.4 per 100,000 women |
| Black | 0.5 per 100,000 men | 0.3 per 100,000 women |
| Asian/Pacific Islander | 0.2 per 100,000 men | 0.2 per 100,000 women |
| American Indian/Alaska Native | ^ per 100,000 men | ^ per 100,000 women |
| Hispanic | 0.7 per 100,000 men | 0.3 per 100,000 women |
Trends in Rates
Trends in rates can be described in many ways. Information for trends over a fixed period of time, for example 1992-2002, can be evaluated by the annual percentage change (APC). If there is a negative sign before the number, the trend is a decrease; otherwise it is an increase. If there is an asterisk after the APC then the trend was significant, that is, one believes that it is beyond chance, i.e. 95% sure, that the increase or decrease is real over the period 1992-2002. If the trend is not significant, the trend is usually reported as stable or level. Joinpoint analyses can be used over a long period of time to evaluate when changes in the trend have occurred along with the APC which shows how much the trend has changed between each of the joinpoints.
The joinpoint trend in SEER cancer incidence with associated APC(%) for Hodgkin lymphoma between 1975-2002 was:
| All Races Male and Female: | -0.2* for 1975-2002 | |||
| All Races Male: | -0.7* for 1975-2002 | |||
| All Races Female: | 0.3* for 1975-2002 |
The joinpoint trend in US cancer mortality with associated APC(%) for Hodgkin lymphoma between 1975-2002 was:
| All Races Male and Female: | -6.7* for 1975-1979; | -3.4* for 1979-2002 | ||
| All Races Male: | -3.9* for 1975-2002 | |||
| All Races Female: | -4.8* for 1975-1985; | -2.6* for 1985-2002 |
Survival
Survival rates can be calculated by different methods for different purposes. The survival rates presented here are based on the relative survival rate, which measures the survival of the cancer patients in comparison to the general population to estimate the effect of cancer. The overall 5-year relative survival rate for 1995-2001 from 9 SEER geographic areas was 85.3%. Five-year relative survival rates by race and sex were: 84.6% for white men; 87.7% for white women; 77.8% for black men; 83.3% for black women.
Lifetime Risk
Based on rates from 2000-2002, 0.21% of men and women born today will be diagnosed with Hodgkin lymphoma at some time during their lifetime. This number can also be expressed as 1 in 475 men and women will be diagnosed with Hodgkin lymphoma during their lifetime. These statistics are called the lifetime risk of developing cancer. Sometimes it is more useful to look at the probability of developing Hodgkin lymphoma between two age groups. For example, 0.06% of men will develop Hodgkin lymphoma between their 50th and 70th birthdays compared to 0.04% for women.
Prevalence
On January 1, 2002, in the United States there were approximately 145,501 men and women alive who had a history of Hodgkin lymphoma -- 76,257 men and 69,244 women. This includes any person alive on January 1, 2002 who had been diagnosed with Hodgkin lymphoma at any point prior to January 1, 2002 and includes persons with active disease and those who are cured of their disease. Prevalence can also be expressed as a percentage and it can also be calculated for a specific amount of time prior to January 1, 2002 such as disgnosed within 5 years of January 1, 2002.
Source: National Cancer Institute www.cancer.gov
see also:
Liver
Liver Cancer Lawsuit Toxic Tort Lawyers/AttorneysLiver Toxic Tort Lawsuit Lawyer/Attorney
Myeloma
Myeloma Cancer Lawsuit Toxic Tort Lawyers/AttorneysMyeloma Toxic Tort Lawsuit Lawyer/Attorney
Cancers K - O
Environmental Cancer Lawsuit: Cancers cause by Pollutants--Free Eval.Get A Free Review of Your Cancer Lawsuit from an Environmental Lawyer
